Skip to main content

Peer Review reports

From: Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing

Original Submission
29 Nov 2020 Submitted Original manuscript
11 Dec 2020 Reviewed Reviewer Report - Na Li
14 May 2021 Reviewed Reviewer Report
9 Jun 2021 Reviewed Reviewer Report
19 Jul 2021 Author responded Author comments - ASIM BIKAS DAS
Resubmission - Version 2
19 Jul 2021 Submitted Manuscript version 2
26 Jul 2021 Author responded Author comments - ASIM BIKAS DAS
Resubmission - Version 3
26 Jul 2021 Submitted Manuscript version 3
26 Jul 2021 Reviewed Reviewer Report
28 Jul 2021 Reviewed Reviewer Report - Na Li
11 Aug 2021 Reviewed Reviewer Report
12 Aug 2021 Author responded Author comments - ASIM BIKAS DAS
Resubmission - Version 4
12 Aug 2021 Submitted Manuscript version 4
3 Sep 2021 Author responded Author comments - ASIM BIKAS DAS
Resubmission - Version 5
3 Sep 2021 Submitted Manuscript version 5
6 Sep 2021 Author responded Author comments - ASIM BIKAS DAS
Resubmission - Version 6
6 Sep 2021 Submitted Manuscript version 6
Publishing
8 Sep 2021 Editorially accepted
17 Sep 2021 Article published 10.1186/s12920-021-01079-7

You can find further information about peer review here.

Back to article page